Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dae Ryong Cha

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Diabetes, Obesity & Metabolism|July 19, 2017
Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40-week extension of the GUARD randomized studySang Youb Han, Sun Ae Yoon, Byoung Geun Han, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 7, 2017
APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injuryJin Joo Cha, Hye Sook Min, Ki Tae Kim, et al.
Kidney Research and Clinical Practice|February 16, 2016
Serum calcium and phosphorus levels in patients undergoing maintenance hemodialysis: A multicentre study in KoreaGheun-Ho Kim, Bum Soon Choi, Dae Ryong Cha, et al.
Nephron|August 21, 2002
Insomnia in diabetic hemodialysis patients. Prevalence and risk factors by a multicenter studySang-Youb Han, Jong-Woo Yoon, Sang-Kyung Jo, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Diabetes, Obesity & Metabolism|July 19, 2017
Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40-week extension of the GUARD randomized studySang Youb Han, Sun Ae Yoon, Byoung Geun Han, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 7, 2017
APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injuryJin Joo Cha, Hye Sook Min, Ki Tae Kim, et al.
Kidney Research and Clinical Practice|February 16, 2016
Serum calcium and phosphorus levels in patients undergoing maintenance hemodialysis: A multicentre study in KoreaGheun-Ho Kim, Bum Soon Choi, Dae Ryong Cha, et al.
Nephron|August 21, 2002
Insomnia in diabetic hemodialysis patients. Prevalence and risk factors by a multicenter studySang-Youb Han, Jong-Woo Yoon, Sang-Kyung Jo, et al.
Pageof 9